Envoy Medical, Inc. Stock

Equities

COCH

US29415V1098

Advanced Medical Equipment & Technology

End-of-day quote Nasdaq 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
2.99 USD -1.64% Intraday chart for Envoy Medical, Inc. -10.75% +65.14%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 400K Sales 2025 * 350K Capitalization 59.19M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 148 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 169 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 34
Yield 2024 *
-
Yield 2025 *
-
Free-Float 31.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.64%
1 week-10.75%
Current month-29.65%
1 month-49.75%
3 months+118.25%
6 months+214.74%
Current year+65.14%
More quotes
1 week
2.89
Extreme 2.89
3.42
1 month
2.85
Extreme 2.85
5.93
Current year
1.08
Extreme 1.08
11.46
1 year
0.75
Extreme 0.7473
11.72
3 years
0.75
Extreme 0.7473
11.72
5 years
0.75
Extreme 0.7473
11.72
10 years
0.75
Extreme 0.7473
11.72
More quotes
Date Price Change Volume
24-05-16 3.02 +1.00% 19,732
24-05-15 2.99 -1.64% 46,839
24-05-14 3.04 -1.94% 41,408
24-05-13 3.1 -2.82% 15,108
24-05-10 3.19 -4.78% 34,986

End-of-day quote Nasdaq, May 14, 2024

More quotes
Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.02 USD
Average target price
5.5 USD
Spread / Average Target
+82.12%
Consensus

Quarterly revenue - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW